Taizo A. Nakano

Hematology | Oncology
13123 E 16th Ave
Aurora, CO 80045

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Terminal Complement Inhibition for Refractory IgA-Mediated Autoimmune Hemolytic Anemia in a Pediatric Heart Transplant Recipient.

Terminal Complement Inhibition for Refractory IgA-Mediated Autoimmune Hemolytic Anemia in a Pediatric Heart Transplant Recipient.

Journal: Pediatric blood & cancer
Published: June 23, 2026

Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders.

Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders.

Journal: Blood advances
Published: February 05, 2026

Multicenter initiative to standardize management of pediatric immune thrombocytopenia improves adherence to guidelines.

Multicenter initiative to standardize management of pediatric immune thrombocytopenia improves adherence to guidelines.

Journal: Blood advances
Published: October 23, 2025

Multicenter initiative to standardize management of pediatric immune thrombocytopenia improves adherence to guidelines.

Multicenter initiative to standardize management of pediatric immune thrombocytopenia improves adherence to guidelines.

Journal: Blood advances
Published: October 23, 2025

Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial.

Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial.

Journal: JAMA
Published: October 22, 2025

A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia Consortium.

A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia Consortium.

Journal: Journal of pediatric hematology/oncology
Published: October 04, 2025

VA-Comm: Developing and Piloting a Novel Communication Tool for Complex Lymphatic Anomalies and Lymphatic Malformations.

VA-Comm: Developing and Piloting a Novel Communication Tool for Complex Lymphatic Anomalies and Lymphatic Malformations.

Journal: Pediatric blood & cancer
Published: August 04, 2025

Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary.

Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary.

Journal: Immunotherapy
Published: June 18, 2025

Diagnostic Implications and Correlates of Plasma Adenosine Deaminase 2 Activity and ADA2 Variants.

Diagnostic Implications and Correlates of Plasma Adenosine Deaminase 2 Activity and ADA2 Variants.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 17, 2025

Congenital and Acquired Pediatric Bone Marrow Failure.

Congenital and Acquired Pediatric Bone Marrow Failure.

Journal: Pediatrics in review
Published: March 06, 2025

Working toward international consensus defining pediatric "refractory ITP".

Working toward international consensus defining pediatric "refractory ITP".

Journal: Blood advances
Published: December 17, 2024

Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial.

Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial.

Journal: Blood advances
Published: December 11, 2024
Showing 1-12 of 46

Last Updated: 09/26/2026